BRISTOL MYERS SQUIBB CO (CELG-RI) is a Health Care company in the Pharmaceutical Preparations industry (SEC CIK 0000014272). Annual revenue was $48.19B in FY2025, compared to $46.38B in FY2021. Net income in FY2025 was $7.05B (diluted EPS $3.46).
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $48.19B | $48.30B | $45.01B | $46.16B | $46.38B |
| Gross Profit | $34.26B | $34.33B | $34.31B | $36.02B | $36.45B |
| Operating Income | — | — | — | — | — |
| Net Income | $7.05B | negative: -$8.95B | $8.03B | $6.33B | $6.99B |
| EPS (Diluted) | $3.46 | negative: -$4.41 | $3.86 | $2.95 | $3.12 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $14.16B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 71.1% |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001140361-26-020036 | May 5, 2026 | May 8, 2026 | May 8, 2026 20:10 UTC | EDGAR |
| 8-K | 0000014272-26-000008 | Apr 30, 2026 | Apr 30, 2026 | Apr 30, 2026 11:01 UTC | EDGAR |
| 10-Q | 0000014272-26-000010 | Mar 31, 2026 | Apr 30, 2026 | Apr 30, 2026 15:44 UTC | EDGAR |
| 10-K | 0000014272-26-000004 | Dec 31, 2025 | Feb 11, 2026 | Feb 11, 2026 16:35 UTC | EDGAR |
| 8-K | 0000014272-26-000002 | Feb 5, 2026 | Feb 5, 2026 | Feb 5, 2026 12:07 UTC | EDGAR |
| 8-K | 0001140361-26-000929 | Jan 12, 2026 | Jan 12, 2026 | Jan 12, 2026 15:20 UTC | EDGAR |
| 8-K | 0001140361-25-042607 | Nov 17, 2025 | Nov 18, 2025 | Nov 18, 2025 21:41 UTC | EDGAR |
| 8-K | 0001140361-25-041380 | Oct 31, 2025 | Nov 10, 2025 | Nov 10, 2025 21:06 UTC | EDGAR |
Direct links to SEC EDGAR. CELG-RI has additional filings available on the SEC site.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $92.60B |
| $95.16B |
| $96.82B |
| $109.31B |
| Total Liabilities | $71.53B | $76.22B | $65.67B | $65.70B | $73.31B |
|---|
| Stockholders' Equity | $18.51B | $16.39B | $29.48B | $31.12B | $36.01B |
|---|
| Cash & Equivalents | $10.21B | $10.35B | $11.52B | $9.32B | $14.32B |
|---|
| Total Debt | — | — | $4.50B | $6.00B | — |
|---|
| $15.19B |
| $13.86B |
| $13.07B |
| $16.21B |
| Capital Expenditures | $1.31B | $1.25B | $1.21B | $1.12B | $0.97B |
|---|
| Free Cash Flow | $12.85B | $13.94B | $12.65B | $11.95B | $15.23B |
|---|
| 76.2% |
| 78.0% |
| 78.6% |
| Operating Margin | 0.3% | negative: -0.1% | 0.1% | 0.2% | — |
|---|
| Net Margin | 0.1% | negative: -0.2% | 0.2% | 0.1% | 15.1% |
|---|
| Return on Equity | 40.4% | negative: -39.0% | 26.5% | 18.9% | 19.4% |
|---|
| Return on Assets | 7.7% | negative: -9.5% | 8.4% | 6.1% | 6.4% |
|---|
| Debt / Equity | 2.65× | 3.25× | 0.15× | 0.19× | — |
|---|
